Retisert
NDC 24208-416 · Bausch & Lomb Incorporated
Packages
Billed under HCPCS
J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg Medicare Part B payment limit (ASP + 6%): $338.80
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0168-0059 — fluocinolone acetonide, 0168-0064 — fluocinolone acetonide, 0299-5950 — fluocinolone acetonide, hydroquinone, and tretinoin, 0591-2990 — Fluocinolone Acetonide Topical, 0713-0223 — Fluocinolone Acetonide, 0713-0224 — Fluocinolone Acetonide, 0713-0709 — FLUOCINOLONE ACETONIDE, 21922-003 — Fluocinolone Acetonide Topical Solution USP, 0.01%, 39328-079 — fluocinolone acetonide, 43386-069 — Fluocinolone Acetonide, 43538-900 — fluocinolone acetonide, 43538-910 — fluocinolone acetonide, 43538-940 — neomycin sulfate and fluocinolone acetonide, 45802-009 — Fluocinolone Acetonide, 45802-485 — Fluocinolone acetonide, 45802-887 — fluocinolone acetonide, 50090-6780 — Fluocinolone Acetonide, 50090-7958 — Fluocinolone acetonide, 51672-1356 — Fluocinolone Acetonide, 51672-1357 — Fluocinolone Acetonide, +30 more